LYPD4
gene geneOn this page
Also known as MGC42718
Summary
LYPD4 (LY6/PLAUR domain containing 4, HGNC:28659) is a protein-coding gene on chromosome 19q13.2, encoding Ly6/PLAUR domain-containing protein 4 (Q6UWN0).
Predicted to be located in extracellular region and plasma membrane. Predicted to be active in plasma membrane raft.
Source: NCBI Gene 147719 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 29 total
- MANE Select transcript:
NM_173506
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:28659 |
| Approved symbol | LYPD4 |
| Name | LY6/PLAUR domain containing 4 |
| Location | 19q13.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MGC42718 |
| Ensembl gene | ENSG00000273111 |
| Ensembl biotype | protein_coding |
| Entrez | 147719 |
Gene structure
Transcript identifiers
Ensembl transcripts: 3 — 3 protein_coding
ENST00000343055, ENST00000601246, ENST00000609812
RefSeq mRNA: 2 — MANE Select: NM_173506
NM_001291419, NM_173506
CCDS: CCDS12587, CCDS77303
Canonical transcript exons
ENST00000609812 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003703850 | 41838881 | 41839024 |
| ENSE00003709434 | 41839219 | 41839405 |
| ENSE00003710564 | 41843578 | 41844683 |
| ENSE00003725956 | 41837074 | 41837345 |
| ENSE00003726897 | 41837935 | 41838261 |
Expression profiles
Bgee: expression breadth broad, 34 present calls, max score 99.46.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.6506 / max 638.7363, expressed in 9 samples.
FANTOM5 promoters (9 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 181095 | 0.4706 | 4 |
| 181090 | 0.0815 | 6 |
| 181096 | 0.0431 | 3 |
| 181093 | 0.0159 | 3 |
| 208835 | 0.0157 | 3 |
| 181094 | 0.0123 | 3 |
| 181097 | 0.0066 | 3 |
| 181091 | 0.0027 | 1 |
| 181092 | 0.0023 | 1 |
Top tissues by expression
217 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| sperm | CL:0000019 | 99.46 | gold quality |
| left testis | UBERON:0004533 | 97.17 | gold quality |
| right testis | UBERON:0004534 | 97.06 | gold quality |
| testis | UBERON:0000473 | 93.81 | gold quality |
| adult organism | UBERON:0007023 | 91.77 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 84.86 | gold quality |
| tibialis anterior | UBERON:0001385 | 75.47 | silver quality |
| oocyte | CL:0000023 | 75.27 | gold quality |
| secondary oocyte | CL:0000655 | 75.18 | gold quality |
| kidney epithelium | UBERON:0004819 | 73.43 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 72.24 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 70.20 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 69.97 | gold quality |
| ileal mucosa | UBERON:0000331 | 69.39 | silver quality |
| upper arm skin | UBERON:0004263 | 66.92 | gold quality |
| deltoid | UBERON:0001476 | 61.06 | gold quality |
| myocardium | UBERON:0002349 | 58.68 | gold quality |
| pancreatic ductal cell | CL:0002079 | 58.20 | silver quality |
| superficial temporal artery | UBERON:0001614 | 55.66 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 55.29 | gold quality |
| tendon of biceps brachii | UBERON:0008188 | 55.09 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 54.43 | gold quality |
| quadriceps femoris | UBERON:0001377 | 53.32 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 51.15 | gold quality |
| vastus lateralis | UBERON:0001379 | 51.07 | gold quality |
| body of tongue | UBERON:0011876 | 48.17 | gold quality |
| muscle tissue | UBERON:0002385 | 47.41 | gold quality |
| blood | UBERON:0000178 | 46.77 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 46.49 | gold quality |
| cauda epididymis | UBERON:0004360 | 44.95 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 2.30 |
Regulation
Is transcription factor: no
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Lypd4 | ENSMUSG00000062732 |
| rattus_norvegicus | Lypd4 | ENSRNOG00000020098 |
Paralogs (2): TEX101 (ENSG00000131126), CD177 (ENSG00000204936)
Protein
Protein identifiers
Ly6/PLAUR domain-containing protein 4 — Q6UWN0 (reviewed: Q6UWN0)
All UniProt accessions (2): A8K8E0, Q6UWN0
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Cell membrane.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q6UWN0-1 | 1 | yes |
| Q6UWN0-2 | 2 |
RefSeq proteins (2): NP_001278348, NP_775777* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR016054 | LY6_UPA_recep-like | Domain |
| IPR045860 | Snake_toxin-like_sf | Homologous_superfamily |
| IPR051899 | Fert-Immune_med_protein | Family |
Pfam: PF00021
UniProt features (9 total): signal peptide 1, chain 1, propeptide 1, domain 1, lipid moiety-binding region 1, glycosylation site 1, splice variant 1, sequence variant 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q6UWN0-F1 | 84.87 | 0.62 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 225
Glycosylation sites (1): 117
Function
Pathways and Gene Ontology
Reactome pathways
3 pathways
| ID | Pathway |
|---|---|
| R-HSA-163125 | Post-translational modification: synthesis of GPI-anchored proteins |
| R-HSA-392499 | Metabolism of proteins |
| R-HSA-597592 | Post-translational protein modification |
MSigDB gene sets: 41 (showing top):
GOBP_SINGLE_FERTILIZATION, GOCC_SECRETORY_GRANULE, GOBP_SPERM_EGG_RECOGNITION, GOBP_FERTILIZATION, GOBP_CELL_CELL_RECOGNITION, GOBP_BINDING_OF_SPERM_TO_ZONA_PELLUCIDA, GOCC_SECRETORY_VESICLE, GOCC_SIDE_OF_MEMBRANE, GOCC_ACROSOMAL_VESICLE, GOCC_PLASMA_MEMBRANE_REGION, GOCC_PLASMA_MEMBRANE_RAFT, MIKKELSEN_IPS_HCP_WITH_H3_UNMETHYLATED, REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION, MIKKELSEN_ES_HCP_WITH_H3K27ME3, MIKKELSEN_MEF_HCP_WITH_H3K27ME3
GO Biological Process (3): binding of sperm to zona pellucida (GO:0007339), sperm migration through the uterotubal junction (GO:0160131), single fertilization (GO:0007338)
GO Molecular Function (0):
GO Cellular Component (6): acrosomal vesicle (GO:0001669), extracellular region (GO:0005576), plasma membrane (GO:0005886), plasma membrane raft (GO:0044853), side of membrane (GO:0098552), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-2 pathways:
| Category | Pathways |
|---|---|
| Post-translational protein modification | 1 |
| Metabolism of proteins | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 3 |
| membrane | 2 |
| sperm-egg recognition | 1 |
| cell migration | 1 |
| multicellular organismal reproductive process | 1 |
| fertilization | 1 |
| secretory granule | 1 |
| cell periphery | 1 |
| plasma membrane | 1 |
| membrane raft | 1 |
| plasma membrane region | 1 |
| leaflet of membrane bilayer | 1 |
Protein interactions and networks
STRING
438 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| LYPD4 | LY6H | O94772 | 645 |
| LYPD4 | LY6L | H3BQJ8 | 630 |
| LYPD4 | PATE3 | B3GLJ2 | 625 |
| LYPD4 | LY6K | Q17RY6 | 592 |
| LYPD4 | PATE4 | P0C8F1 | 589 |
| LYPD4 | LYPD2 | Q6UXB3 | 586 |
| LYPD4 | PINLYP | A6NC86 | 586 |
| LYPD4 | SPACA4 | Q8TDM5 | 585 |
| LYPD4 | PATE2 | Q6UY27 | 585 |
| LYPD4 | SLURP1 | P55000 | 582 |
| LYPD4 | DMRTC2 | Q8IXT2 | 571 |
| LYPD4 | PATE1 | Q8WXA2 | 558 |
| LYPD4 | C10orf120 | Q5SQS8 | 557 |
| LYPD4 | LYPD5 | Q6UWN5 | 541 |
| LYPD4 | C5orf47 | Q569G3 | 531 |
IntAct
4 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| LYPD4 | KRAS | psi-mi:“MI:0915”(physical association) | 0.370 |
| LYPD4 | PIK3C2A | psi-mi:“MI:0914”(association) | 0.350 |
| LYPD4 | POTEF | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (171): CBWD3 (Affinity Capture-MS), NPTX2 (Affinity Capture-MS), OBSCN (Affinity Capture-MS), FBXL18 (Affinity Capture-MS), FAM198A (Affinity Capture-MS), NPTX1 (Affinity Capture-MS), ERN1 (Affinity Capture-MS), GDF11 (Affinity Capture-MS), FUT11 (Affinity Capture-MS), PRR14 (Affinity Capture-MS), NBR1 (Affinity Capture-MS), LSS (Affinity Capture-MS), TRMT44 (Affinity Capture-MS), BRIP1 (Affinity Capture-MS), GREB1L (Affinity Capture-MS)
ESM2 similar proteins: B3MFC2, B3NSF6, B4QBL6, B5A5T4, B5E022, D3ZTT2, D4A6L0, H3BQJ8, O43653, P12645, P19438, P22444, P23352, P46657, P49002, P50555, P57096, P58658, P58659, Q16553, Q1RMB5, Q28216, Q32LD3, Q505J3, Q568T5, Q5R510, Q5T848, Q66IA6, Q68US5, Q6UWL2, Q6UWN0, Q6UX15, Q6WN34, Q80XH4, Q86Y78, Q8BHE5, Q8BPP5, Q8BVP6, Q8C351, Q8C419
Diamond homologs: Q32LD3, Q6UWN0, Q8BVP6, Q8N6Q3, Q8R2S8, Q7TQN2, Q924B5, Q9BY14, Q9JMI7
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
29 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 25 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
670 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:41837344:CC:C | acceptor_gain | 0.9900 |
| 19:41837345:CC:C | acceptor_gain | 0.9900 |
| 19:41838018:T:TA | donor_gain | 0.9900 |
| 19:41838077:A:AC | donor_gain | 0.9900 |
| 19:41838078:G:C | donor_gain | 0.9900 |
| 19:41844599:G:C | donor_gain | 0.9900 |
| 19:41838032:G:A | donor_gain | 0.9800 |
| 19:41837345:CCT:C | acceptor_loss | 0.9700 |
| 19:41837346:C:CC | acceptor_gain | 0.9700 |
| 19:41837346:CTGTA:C | acceptor_loss | 0.9700 |
| 19:41837347:T:G | acceptor_loss | 0.9700 |
| 19:41837348:G:C | acceptor_loss | 0.9700 |
| 19:41838022:T:TA | donor_gain | 0.9700 |
| 19:41838087:G:A | donor_gain | 0.9700 |
| 19:41844575:A:C | donor_gain | 0.9700 |
| 19:41844586:AGG:A | donor_gain | 0.9700 |
| 19:41844542:G:C | donor_gain | 0.9600 |
| 19:41838870:G:C | donor_gain | 0.9500 |
| 19:41844505:A:C | donor_gain | 0.9500 |
| 19:41844598:A:AC | donor_gain | 0.9500 |
| 19:41838260:CC:C | acceptor_gain | 0.9400 |
| 19:41838261:CC:C | acceptor_gain | 0.9400 |
| 19:41838869:A:AC | donor_gain | 0.9400 |
| 19:41844428:A:AT | donor_gain | 0.9400 |
| 19:41844496:A:AT | donor_gain | 0.9400 |
| 19:41844509:CAGCG:C | donor_gain | 0.9400 |
| 19:41838259:TCCC:T | acceptor_loss | 0.9300 |
| 19:41838261:CCTGA:C | acceptor_loss | 0.9300 |
| 19:41838263:T:A | acceptor_loss | 0.9300 |
| 19:41844547:G:C | donor_gain | 0.9300 |
AlphaMissense
1597 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:41838233:T:A | K80N | 0.995 |
| 19:41838233:T:G | K80N | 0.995 |
| 19:41838951:C:A | W47C | 0.994 |
| 19:41838951:C:G | W47C | 0.994 |
| 19:41838125:G:C | N116K | 0.993 |
| 19:41838125:G:T | N116K | 0.993 |
| 19:41838234:T:A | K80I | 0.991 |
| 19:41838910:C:G | C61S | 0.990 |
| 19:41838911:A:T | C61S | 0.990 |
| 19:41838953:A:G | W47R | 0.990 |
| 19:41838953:A:T | W47R | 0.990 |
| 19:41838126:T:A | N116I | 0.989 |
| 19:41838129:C:G | C115S | 0.988 |
| 19:41838130:A:T | C115S | 0.988 |
| 19:41839006:C:G | C29S | 0.988 |
| 19:41839007:A:T | C29S | 0.988 |
| 19:41838928:C:G | C55S | 0.987 |
| 19:41838929:A:T | C55S | 0.987 |
| 19:41838957:C:A | W45C | 0.986 |
| 19:41838957:C:G | W45C | 0.986 |
| 19:41838160:A:G | S105P | 0.985 |
| 19:41838228:C:G | C82S | 0.985 |
| 19:41838229:A:T | C82S | 0.985 |
| 19:41838236:A:C | F79L | 0.983 |
| 19:41838236:A:T | F79L | 0.983 |
| 19:41838238:A:G | F79L | 0.983 |
| 19:41838928:C:T | C55Y | 0.982 |
| 19:41838910:C:T | C61Y | 0.981 |
| 19:41838163:C:G | A104P | 0.980 |
| 19:41839005:G:C | C29W | 0.980 |
dbSNP variants (sampled 300 via entrez): RS1000084791 (19:41838926 T>G), RS1000371697 (19:41835132 T>C), RS1000381957 (19:41841204 G>A,T), RS1000560049 (19:41845743 C>G), RS1000579438 (19:41839738 A>G), RS1000684021 (19:41840292 T>A), RS1001117677 (19:41840062 A>G,T), RS1001270419 (19:41842274 C>T), RS1001372761 (19:41836702 A>C,G), RS1001804918 (19:41842563 A>C), RS1003178880 (19:41838476 C>T), RS1003742123 (19:41844359 C>T), RS1004332060 (19:41844100 A>T), RS1004380739 (19:41844317 G>A,T), RS1004665891 (19:41842254 C>T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
2 total (human), top 2 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| CGP 52608 | affects binding, increases reaction | 1 |
| Benzo(a)pyrene | decreases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.